Rhenman & Partners Asset Management AB
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 13, 2024), Rhenman & Partners Asset Management AB reported 95 stock positions worth $1.2 billion. Its top holding was Boston Scientific (BSX) at 4.0% of the portfolio, followed by Unitedhealth (UNH, 3.4%) and Eli Lilly (LLY, 3.4%). Compared with Q2 2024, it opened 8 new positions, sold out of 6, added to 39 and reduced 39. The biggest buy was Exact Sciences (EXAS, shares +221%) and the biggest sale Elevance Health (ELV, shares −41%).
- Most Recent 13F
- Q2 2026
- Location
- Stockholm, V7
- CIK
- 0001599882
- Portfolio Value
- $1.2B (Q3 2024)
- SEC Filing
- 0001213900-24-097092 ↗ filed Nov 13, 2024
Holdings Value
Holdings 95 stocks · $1.2B
| BSX Boston Scientific Corp. | 4.01% | 590,000 | $49.4M | Reduce -0.8% |
| UNH Unitedhealth Group Inc. | 3.45% | 72,700 | $42.5M | Reduce -31.0% |
| LLY Eli Lilly & Co. | 3.42% | 47,500 | $42.1M | Add +1.1% |
| REGN Regeneron Pharmaceuticals | 3.33% | 39,000 | $41.0M | Add +21.9% |
| THC Tenet Healthcare Corp. | 2.99% | 221,400 | $36.8M | Reduce -3.3% |
| PRCT Procept Biorobotics Corp. | 2.89% | 445,000 | $35.7M | Add +1.1% |
| ABBV Abbvie Inc. | 2.84% | 177,000 | $35.0M | Reduce -6.3% |
| MDT Medtronic PLC | 2.69% | 368,000 | $33.1M | Add +76.9% |
| EXAS Exact Sciences Corp. | 2.57% | 465,000 | $31.7M | Add +220.7% |
| HCA HCA Healthcare Inc. | 2.51% | 76,229 | $31.0M | Reduce -7.0% |
| ISRG Intuitive Surgical Inc. | 2.51% | 63,000 | $31.0M | Add +4.1% |
| GILD Gilead Sciences Inc. | 2.49% | 366,500 | $30.7M | Add +53.7% |
| NTRA Natera Inc. | 2.38% | 231,000 | $29.3M | Add +47.1% |
| OSCR Oscar Health Inc. Class A | 2.36% | 1,371,147 | $29.1M | Reduce -28.1% |
| MRK Merck & Co. Inc. | 2.22% | 241,000 | $27.4M | Add +37.7% |
| BDX Becton Dickinson and Co. | 2.20% | 112,500 | $27.1M | Reduce -0.4% |
| ELV Elevance Health Inc. | 2.13% | 50,500 | $26.3M | Reduce -41.1% |
| INSP Inspire Medical Systems Inc. | 2.09% | 122,000 | $25.7M | Add +617.6% |
| BMRN Biomarin Pharmaceutical Inc. | 2.08% | 364,500 | $25.6M | Add +44.9% |
| COO The Cooper Cos Inc. | 2.04% | 228,000 | $25.2M | Reduce -26.4% |
| ALHC Alignment Healthcare Inc. | 1.90% | 1,977,363 | $23.4M | Add +20.5% |
| DHR Danaher Corp. | 1.88% | 83,302 | $23.2M | Add +71.8% |
| VRTX Vertex Pharmaceuticals Inc. | 1.80% | 47,750 | $22.2M | Reduce -11.6% |
| RPRX Royalty Pharma PLC Class A | 1.41% | 613,500 | $17.4M | Add +12.6% |
| TMO Thermo Fisher Scientific Inc. | 1.26% | 25,100 | $15.5M | Add +4.6% |
| ABT Abbott Laboratories | 1.25% | 135,000 | $15.4M | Reduce -6.9% |
| ITCI Intra-Cellular Therapies Inc. | 1.22% | 205,500 | $15.0M | Add +44.7% |
| MCK McKesson Corp. | 1.21% | 30,117 | $14.9M | Add +0.4% |
| GKOS Glaukos Corp. | 1.17% | 111,000 | $14.5M | Add +122.0% |
| CI The Cigna Group | 1.17% | 41,685 | $14.4M | Reduce -43.8% |
| ALGN Align Technology Inc. | 1.14% | 55,000 | $14.0M | Reduce -2.6% |
| ALNY Alnylam Pharmaceuticals Inc. | 1.12% | 50,350 | $13.8M | Reduce -41.1% |
| DVAX Dynavax Technologies Corp. | 1.08% | 1,190,000 | $13.3M | Reduce -3.4% |
| BIIB Biogen Inc. | 1.06% | 67,100 | $13.0M | Reduce -20.9% |
| NVO Novo-Nordisk A/S-Spons ADR | 0.97% | 100,000 | $11.9M | New |
| CVS CVS Health Corp. | 0.94% | 184,000 | $11.6M | New |
| IQV Iqvia Holdings Inc. | 0.92% | 48,000 | $11.4M | Add +54.8% |
| AXSM Axsome Therapeutics Inc. | 0.89% | 122,600 | $11.0M | Reduce -3.9% |
| APLS Apellis Pharmaceuticals Inc. | 0.86% | 367,500 | $10.6M | Add +563.4% |
| JAZZ Jazz Pharmaceuticals PLC | 0.84% | 93,000 | $10.4M | Reduce -18.4% |
| MOH Molina Healthcare Inc. | 0.83% | 29,600 | $10.2M | Add +322.9% |
| COR Cencora Inc. | 0.82% | 45,150 | $10.2M | Reduce -12.3% |
| IOVA Iovance Biotherapeutics Inc. | 0.80% | 1,052,500 | $9.9M | Add +14.4% |
| HUM Humana Inc. | 0.80% | 31,000 | $9.8M | New |
| CYTK Cytokinetics Inc. | 0.77% | 180,500 | $9.5M | Reduce -8.6% |
| INSM Insmed Inc. | 0.77% | 129,513 | $9.5M | Add +30.1% |
| PODD Insulet Corp. | 0.76% | 40,000 | $9.3M | Reduce -14.0% |
| NUVL Nuvalent Inc. Class A | 0.75% | 90,000 | $9.2M | Add +8.8% |
| CNC Centene Corp. | 0.71% | 116,982 | $8.8M | Reduce -41.1% |
| SYK Stryker Corp. | 0.67% | 23,000 | $8.3M | Add +27.8% |
| NBIX Neurocrine Biosciences Inc. | 0.67% | 71,750 | $8.3M | Reduce -5.0% |
| IONS Ionis Pharmaceuticals Inc. | 0.63% | 195,000 | $7.8M | Add +50.0% |
| EVH Evolent Health Inc. Class A | 0.61% | 265,000 | $7.5M | Add +430.0% |
| CRL Charles River Laboratories | 0.60% | 37,500 | $7.4M | Add +10.3% |
| TMDX Transmedics Group Inc. | 0.58% | 45,270 | $7.1M | Add +235.3% |
| IMVT Immunovant Inc. | 0.56% | 243,000 | $6.9M | Add +86.2% |
| BBIO Bridgebio Pharma Inc. | 0.55% | 268,000 | $6.8M | Add +45.3% |
| NRIX Nurix Therapeutics Inc. | 0.55% | 300,000 | $6.7M | Add +72.0% |
| ACHC Acadia Healthcare Co. Inc. | 0.54% | 105,750 | $6.7M | Add +165.5% |
| VKTX Viking Therapeutics Inc. | 0.53% | 102,500 | $6.5M | Reduce -10.9% |
| BNTX Biontech SE-ADR | 0.49% | 51,000 | $6.1M | New |
| EHC Encompass Health Corp. | 0.48% | 61,000 | $5.9M | Add +1.7% |
| DXCM Dexcom Inc. | 0.47% | 87,000 | $5.8M | Reduce -25.6% |
| SNDX Syndax Pharmaceuticals Inc. | 0.41% | 259,500 | $5.0M | Add +13.6% |
| EPIX Essa Pharma Inc. | 0.40% | 804,649 | $4.9M | Reduce -0.2% |
| JANX Janux Therapeutics Inc. | 0.39% | 106,847 | $4.9M | No change |
| GERN Geron Corp. | 0.37% | 1,000,000 | $4.5M | New |
| DNTH Dianthus Therapeutics Inc. | 0.33% | 150,000 | $4.1M | New |
| XNCR Xencor Inc. | 0.33% | 203,750 | $4.1M | Reduce -6.9% |
| MIRM Mirum Pharmaceuticals Inc. | 0.33% | 105,000 | $4.1M | Reduce -21.8% |
| IDYA Ideaya Biosciences Inc. | 0.33% | 127,500 | $4.0M | Add +138.3% |
| TGTX TG Therapeutics Inc. | 0.33% | 171,500 | $4.0M | Reduce -19.7% |
| MRUS Merus NV | 0.32% | 79,500 | $4.0M | Reduce -12.2% |
| ALKS Alkermes PLC | 0.30% | 133,000 | $3.7M | Reduce -11.3% |
| ANNX Annexon Inc. | 0.27% | 560,000 | $3.3M | Reduce -37.8% |
| ESPR Esperion Therapeutics Inc. | 0.26% | 1,975,000 | $3.3M | No change |
| RLAY Relay Therapeutics Inc. | 0.26% | 460,000 | $3.3M | Add +100.0% |
| KURA Kura Oncology Inc. | 0.26% | 166,526 | $3.3M | No change |
| MDGL Madrigal Pharmaceuticals Inc. | 0.26% | 15,300 | $3.2M | Reduce -42.3% |
| ARVN Arvinas Inc. | 0.26% | 130,500 | $3.2M | Reduce -43.3% |
| KRYS Krystal Biotech Inc. | 0.25% | 17,000 | $3.1M | Reduce -10.5% |
| IGMS Igm Biosciences Inc. | 0.25% | 185,459 | $3.1M | Reduce -4.9% |
| BRKR Bruker Corp. | 0.25% | 44,315 | $3.1M | Add +638.6% |
| ACLX Arcellx Inc. | 0.22% | 32,000 | $2.7M | New |
| MEDP Medpace Holdings Inc. | 0.20% | 7,500 | $2.5M | Add +200.0% |
| UHS Universal Health Services-B | 0.15% | 8,000 | $1.8M | New |
| IMCR Immunocore Holdings PLC-ADR | 0.15% | 58,278 | $1.8M | No change |
| PRVA Privia Health Group Inc. | 0.14% | 95,189 | $1.7M | Reduce -16.5% |
| TECH Bio-Techne Corp. | 0.13% | 20,000 | $1.6M | No change |
| RGEN Repligen Corp. | 0.12% | 10,000 | $1.5M | No change |
| XENE Xenon Pharmaceuticals Inc. | 0.11% | 35,000 | $1.4M | No change |
| PLRX Pliant Therapeutics Inc. | 0.11% | 120,250 | $1.3M | No change |
| AVTR Avantor Inc. | 0.09% | 44,000 | $1.1M | Reduce -26.7% |
| AMGN Amgen Inc. | 0.08% | 3,000 | $967K | Reduce -29.4% |
| INMB Inmune Bio Inc. | 0.08% | 178,284 | $961K | No change |
Portfolio Sells Q2 2024 → Q3 2024
| ELV Elevance Health Inc. | Reduce -41.1% | 2.13% | −2.33 |
| UNH Unitedhealth Group Inc. | Reduce -31.0% | 3.45% | −1.70 |
| CI The Cigna Group | Reduce -43.8% | 1.17% | −1.18 |
| ALNY Alnylam Pharmaceuticals Inc. | Reduce -41.1% | 1.12% | −0.87 |
| EW Edwards Lifesciences Corp. | Sold out | 0.00% | −0.86 |
| BIIB Biogen Inc. | Reduce -20.9% | 1.06% | −0.83 |
| DXCM Dexcom Inc. | Reduce -25.6% | 0.47% | −0.80 |
| VRTX Vertex Pharmaceuticals Inc. | Reduce -11.6% | 1.80% | −0.63 |
| COO The Cooper Cos Inc. | Reduce -26.4% | 2.04% | −0.56 |
| CNC Centene Corp. | Reduce -41.1% | 0.71% | −0.55 |
| OSCR Oscar Health Inc. Class A | Reduce -28.1% | 2.36% | −0.54 |
| MDGL Madrigal Pharmaceuticals Inc. | Reduce -42.3% | 0.26% | −0.45 |
| PEN Penumbra Inc. | Sold out | 0.00% | −0.40 |
| BSX Boston Scientific Corp. | Reduce -0.8% | 4.01% | −0.39 |
| BDX Becton Dickinson and Co. | Reduce -0.4% | 2.20% | −0.33 |
| NBIX Neurocrine Biosciences Inc. | Reduce -5.0% | 0.67% | −0.33 |
| JAZZ Jazz Pharmaceuticals PLC | Reduce -18.4% | 0.84% | −0.33 |
| ARVN Arvinas Inc. | Reduce -43.3% | 0.26% | −0.33 |
| STAA Staar Surgical Co. | Sold out | 0.00% | −0.30 |
| COR Cencora Inc. | Reduce -12.3% | 0.82% | −0.29 |
| ABBV Abbvie Inc. | Reduce -6.3% | 2.84% | −0.28 |
| CYTK Cytokinetics Inc. | Reduce -8.6% | 0.77% | −0.25 |
| DVAX Dynavax Technologies Corp. | Reduce -3.4% | 1.08% | −0.25 |
| ABT Abbott Laboratories | Reduce -6.9% | 1.25% | −0.20 |
| MRUS Merus NV | Reduce -12.2% | 0.32% | −0.19 |
| ALGN Align Technology Inc. | Reduce -2.6% | 1.14% | −0.17 |
| RVNC Revance Therapeutics Inc. | Sold out | 0.00% | −0.17 |
| ANNX Annexon Inc. | Reduce -37.8% | 0.27% | −0.15 |
| PODD Insulet Corp. | Reduce -14.0% | 0.76% | −0.15 |
| MIRM Mirum Pharmaceuticals Inc. | Reduce -21.8% | 0.33% | −0.11 |
| NARI Inari Medical Inc. | Sold out | 0.00% | −0.09 |
| AXSM Axsome Therapeutics Inc. | Reduce -3.9% | 0.89% | −0.09 |
| AUGX Augmedix Inc. | Sold out | 0.00% | −0.08 |
| KRYS Krystal Biotech Inc. | Reduce -10.5% | 0.25% | −0.08 |
| XNCR Xencor Inc. | Reduce -6.9% | 0.33% | −0.07 |
| VKTX Viking Therapeutics Inc. | Reduce -10.9% | 0.53% | −0.06 |
| PRVA Privia Health Group Inc. | Reduce -16.5% | 0.14% | −0.05 |
| AMGN Amgen Inc. | Reduce -29.4% | 0.08% | −0.05 |
| ALKS Alkermes PLC | Reduce -11.3% | 0.30% | −0.04 |
| TGTX TG Therapeutics Inc. | Reduce -19.7% | 0.33% | −0.04 |
| AVTR Avantor Inc. | Reduce -26.7% | 0.09% | −0.03 |
| HCA HCA Healthcare Inc. | Reduce -7.0% | 2.51% | −0.01 |
| EPIX Essa Pharma Inc. | Reduce -0.2% | 0.40% | −0.01 |
| THC Tenet Healthcare Corp. | Reduce -3.3% | 2.99% | +0.06 |
| IGMS Igm Biosciences Inc. | Reduce -4.9% | 0.25% | +0.12 |
Portfolio Buys Q2 2024 → Q3 2024
| EXAS Exact Sciences Corp. | Add +220.7% | 2.57% | +1.98 |
| INSP Inspire Medical Systems Inc. | Add +617.6% | 2.09% | +1.87 |
| MDT Medtronic PLC | Add +76.9% | 2.69% | +1.12 |
| NVO Novo-Nordisk A/S-Spons ADR | New | 0.97% | +0.97 |
| CVS CVS Health Corp. | New | 0.94% | +0.94 |
| GILD Gilead Sciences Inc. | Add +53.7% | 2.49% | +0.92 |
| HUM Humana Inc. | New | 0.80% | +0.80 |
| NTRA Natera Inc. | Add +47.1% | 2.38% | +0.75 |
| DHR Danaher Corp. | Add +71.8% | 1.88% | +0.72 |
| ALHC Alignment Healthcare Inc. | Add +20.5% | 1.90% | +0.66 |
| APLS Apellis Pharmaceuticals Inc. | Add +563.4% | 0.86% | +0.66 |
| MOH Molina Healthcare Inc. | Add +322.9% | 0.83% | +0.63 |
| GKOS Glaukos Corp. | Add +122.0% | 1.17% | +0.61 |
| EVH Evolent Health Inc. Class A | Add +430.0% | 0.61% | +0.52 |
| BNTX Biontech SE-ADR | New | 0.49% | +0.49 |
| TMDX Transmedics Group Inc. | Add +235.3% | 0.58% | +0.38 |
| GERN Geron Corp. | New | 0.37% | +0.37 |
| DNTH Dianthus Therapeutics Inc. | New | 0.33% | +0.33 |
| PRCT Procept Biorobotics Corp. | Add +1.1% | 2.89% | +0.31 |
| IQV Iqvia Holdings Inc. | Add +54.8% | 0.92% | +0.29 |
| ITCI Intra-Cellular Therapies Inc. | Add +44.7% | 1.22% | +0.29 |
| ACHC Acadia Healthcare Co. Inc. | Add +165.5% | 0.54% | +0.29 |
| IMVT Immunovant Inc. | Add +86.2% | 0.56% | +0.23 |
| ACLX Arcellx Inc. | New | 0.22% | +0.22 |
| BRKR Bruker Corp. | Add +638.6% | 0.25% | +0.21 |
| NRIX Nurix Therapeutics Inc. | Add +72.0% | 0.55% | +0.20 |
| UHS Universal Health Services-B | New | 0.15% | +0.15 |
| IDYA Ideaya Biosciences Inc. | Add +138.3% | 0.33% | +0.15 |
| NUVL Nuvalent Inc. Class A | Add +8.8% | 0.75% | +0.14 |
| MRK Merck & Co. Inc. | Add +37.7% | 2.22% | +0.14 |
| INSM Insmed Inc. | Add +30.1% | 0.77% | +0.13 |
| RLAY Relay Therapeutics Inc. | Add +100.0% | 0.26% | +0.12 |
| BBIO Bridgebio Pharma Inc. | Add +45.3% | 0.55% | +0.11 |
| MEDP Medpace Holdings Inc. | Add +200.0% | 0.20% | +0.10 |
| REGN Regeneron Pharmaceuticals | Add +21.9% | 3.33% | +0.10 |
| IOVA Iovance Biotherapeutics Inc. | Add +14.4% | 0.80% | +0.09 |
| BMRN Biomarin Pharmaceutical Inc. | Add +44.9% | 2.08% | +0.09 |
| SYK Stryker Corp. | Add +27.8% | 0.67% | +0.09 |
| IONS Ionis Pharmaceuticals Inc. | Add +50.0% | 0.63% | +0.04 |
| RPRX Royalty Pharma PLC Class A | Add +12.6% | 1.41% | +0.03 |
| TMO Thermo Fisher Scientific Inc. | Add +4.6% | 1.26% | −0.01 |
| EHC Encompass Health Corp. | Add +1.7% | 0.48% | −0.02 |
| SNDX Syndax Pharmaceuticals Inc. | Add +13.6% | 0.41% | −0.04 |
| ISRG Intuitive Surgical Inc. | Add +4.1% | 2.51% | −0.07 |
| CRL Charles River Laboratories | Add +10.3% | 0.60% | −0.07 |
| MCK McKesson Corp. | Add +0.4% | 1.21% | −0.47 |
| LLY Eli Lilly & Co. | Add +1.1% | 3.42% | −0.67 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 99 | $1.1B | UNH, CVS, AZN, MRK, LLY |
| Q1 2026 | 86 | $810.5M | BSX, REGN, LLY, INSM, CVS |
| Q4 2025 | 94 | $1.1B | REGN, LLY, BSX, MDT, ISRG |
| Q3 2025 | 92 | $903.7M | BSX, LLY, ABBV, DHR, ALHC |
| Q2 2025 | 90 | $791.0M | LLY, BSX, VRTX, GKOS, ISRG |
| Q1 2025 | 94 | $870.0M | UNH, LLY, VRTX, MCK, BSX |
| Q4 2024 | 92 | $972.9M | BSX, LLY, PRCT, ISRG, REGN |
| Q3 2024 | 95 | $1.2B | BSX, UNH, LLY, REGN, THC |
| Q2 2024 | 93 | $1.0B | UNH, ELV, BSX, LLY, REGN |
| Q1 2024 | 84 | $1.1B | CI, LLY, THC, BSX, ELV |